Estrella Immunopharma 

$0.6358
5
-$0.01-0.81% 18:07 Today

Statistics

Day High
0.725
Day Low
0.585
52W High
3.15
52W Low
0.585
Volume
67,124
Avg. Volume
36,385
Mkt Cap
27.66M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

2DecExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.19
-0.14
-0.1
-0.05
Expected EPS
-0.08
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2021
2022
2023
2024
2025
0Revenue
-13.06MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ESLA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
Show more...
CEO
Cheng Liu
Employees
3
Country
United States
ISIN
US2975841048

Listings

0 Comments

Share your thoughts

FAQ

What is Estrella Immunopharma stock price today?
The current price of ESLA is $0.64 USD — it has decreased by -0.81% in the past 24 hours. Watch Estrella Immunopharma stock price performance more closely on the chart.
What is Estrella Immunopharma stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Estrella Immunopharma stocks are traded under the ticker ESLA.
Is Estrella Immunopharma stock price growing?
ESLA stock has fallen by -9.83% compared to the previous week, the month change is a -9.69% fall, over the last year Estrella Immunopharma has showed a -41.13% decrease.
What is Estrella Immunopharma market cap?
Today Estrella Immunopharma has the market capitalization of 27.66M
When is the next Estrella Immunopharma earnings date?
Estrella Immunopharma is going to release the next earnings report on December 02, 2026.
What is Estrella Immunopharma revenue for the last year?
Estrella Immunopharma revenue for the last year amounts to 0 USD.
What is Estrella Immunopharma net income for the last year?
ESLA net income for the last year is -13.06M USD.
How many employees does Estrella Immunopharma have?
As of September 04, 2026, the company has 3 employees.
In which sector is Estrella Immunopharma located?
Estrella Immunopharma operates in the Health & Wellness sector.
When did Estrella Immunopharma complete a stock split?
Estrella Immunopharma has not had any recent stock splits.
Where is Estrella Immunopharma headquartered?
Estrella Immunopharma is headquartered in EMERYVILLE, United States.